HLA Typing for Transplant Market Size

  • Report ID: 2629
  • Published Date: Jun 02, 2025
  • Report Format: PDF, PPT

Global HLA Typing for Transplant Market Size, Forecast, and Trend Highlights Over 2025-2037

HLA Typing for Transplant Market size was valued at USD 1.4 billion in 2024 and is projected to reach USD 3.8 billion by the end of 2037, rising at a CAGR of 8.1% during the forecast period, i.e., 2025-2037. In 2025, the industry size of HLA typing for transplant is estimated at USD 1.6 billion.

The global HLA typing for transplant market is expanding at a rapid pace due to its large consumer base being affected by end-stage renal disease, leukemia, and solid organ failures. According to the WHO report published in 2024, the patient pool requiring HLA typing for transplants reached approximately 1.1 million cases in a year, reflecting the increased demand. Besides, the supply chain of these reagents relies on several raw materials such as DNA polymerases, fluorescent probes, and microarrays, which are currently being imported from the U.S., Germany, and Japan, further contributing to wider market upliftment.

Governments across the nations are initiating funding towards the market upliftment for research activities that bring innovation in the field. In this regard, the EU’s Horizon Europe program assigned €160 million for portable HLA typing systems, aiming to streamline transplant logistics. Furthermore, the global trade in the market is positively impacting industrial expansion internationally by reaching USD 860 million in 2024, with the U.S. and Germany leading exports, and the developing nations India and China dominate the imports, thereby drawing the interest of key leaders to invest in this sector.


HLA Typing for Transplant Market Size

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of HLA typing for transplant is evaluated at USD 1.6 billion.

HLA Typing for Transplant Market size was over USD 1.4 billion in 2024 and is projected to reach USD 3.8 billion by 2037, witnessing around 8.1% CAGR during the forecast period i.e., between 2025-2037.

North America industry is expected to account for largest revenue share of 47.5% by 2037, on account of the presence of a highly developed healthcare system, large volume of organ transplantation procedures performed in the region.

The major players in the market are Thermo Fisher Scientific, Illumina, QIAGEN, Bio-Rad Laboratories, Roche Diagnostics, Immucor (Werfen), Becton Dickinson (BD), Luminex (DiaSorin), Takara Bio, CareDx, Omixon, GenDx, Abbott Laboratories, Sysmex, SeCore (Life Technologies), Histogenetics, Cytologics, TBG Diagnostics, XCyton Diagnostics, Inno-Train Diagnostics
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos